September 30, 2021 | 1:30 – 2:15 PM (ET) | 30-Minute Presentation Followed by Q&A
On August 4, 2021, the Eighth Amendment of the Declaration Under the Public Readiness and Emergency Preparedness (PREP) Act for Medical Countermeasures Against COVID-19 was issued. One week later, the CDC and FDA announced approval of a third dose of COVID vaccine for specific high-risk patients who have completed their mRNA vaccine series. With influenza vaccine season approaching, pharmacists have a lot to prepare for. Our interactive session will cover:
- How the Eighth Amendment to the PREP Act impacts immunizing pharmacists and their vaccine administration workflow
- Patient eligibility for the third dose of mRNA COVID vaccine
- Documentation and billing of the third dose of COVID vaccine
- Overlap of COVID booster and influenza vaccine patient demand